RxDoctor Payments Data

Randall Wright, MD

Neurology · Houston, TXNPI 1316035058

Payments from drug & device makers

$22,716in general payments, 2019–2025

Across 1,070 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • AbbVie$2K
  • Eisai Inc.$1K
  • Novartis$1K
  • Lilly USA, LLC$947
  • UCB, Inc.$917
  • plus $12K from 54 others

What the payments were for

  • Speaking & faculty fees$3,15014%
  • Food & beverage$19,23285%
  • Education$3341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer61$4,092
AbbVie(2 entities)111$1,712
Eisai Inc.66$1,423
Novartis80$1,172
Lilly USA, LLC72$947
UCB, Inc.35$917
Teva Pharmaceuticals USA, Inc.54$861
SK Life Science, Inc.42$812
Biogen33$554
Jazz Pharmaceuticals Inc.17$537
AstraZeneca(2 entities)26$512
EMD Serono, Inc.25$494
Neurocrine Biosciences, Inc.26$485
Inspire Medical Systems, Inc.26$460
Sunovion Pharmaceuticals Inc.33$444
Otsuka America Pharmaceutical, Inc.23$414
Lundbeck LLC23$409
Supernus Pharmaceuticals, Inc.25$365
Amgen(2 entities)15$357
Biohaven Pharmaceuticals, Inc.19$345
Genentech USA, Inc.18$301
Adamas Pharmaceuticals, Inc.12$299
Sanofi18$296
Biohaven Pharmaceutical Holding Company Ltd.21$290
MDD US Operations, LLC15$262
Argenx US, Inc.6$256
Harmony Biosciences LLC12$255
Averitas Pharma Inc.14$239
Abbott11$223
Acadia Pharmaceuticals Inc8$187
TG Therapeutics, Inc.5$185
Novo Nordisk3$180
Boston Scientific4$138
GE HealthCare6$133
Itamar Medical Inc1$125
Medtronic2$124
Neurelis, Inc.5$119
Livanova USA, Inc.6$117
Upsher-smith Laboratories LLC6$112
Nevro Corp.2$109
GRT US Holding, Inc.9$109
Catalyst Pharmaceuticals, Inc.5$96
Axsome Therapeutics, Inc.3$89
Takeda Pharmaceuticals U.S.A., Inc.4$85
Sumitomo Pharma America, Inc.9$83
Assertio Therapeutics, Inc.4$83
Greenwich Biosciences, Inc.4$75
Amneal Pharmaceuticals LLC4$75
Aquestive Therapeutics, Inc.5$69
Merz Pharmaceuticals, LLC2$67
Johnson & Johnson(2 entities)2$57
Avadel CNS Pharmaceuticals, LLC2$54
Bristol Myers Squibb2$52
Azurity Pharmaceuticals, Inc.2$49
Corium, LLC3$47
Aucta Pharmaceuticals, Inc.4$47
Impel Pharmaceuticals Inc.2$41
Merz North America, Inc.2$39
Sanofi-aventis U.S. LLC2$33
Insightec,inc3$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,716 in reported general payments places this provider in the 75th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas

Medicare billing

Part B allowed, 2024
$274,217
Medicare patients
456
Services billed
1,924

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate46$69,452
BriviactBrivaracetam26$39,118
QuliptaAtogepant31$34,786
Emgality PenGalcanezumab-Gnlm43$33,540
XcopriCenobamate26$31,678
FycompaPerampanel29$30,527
AptiomEslicarbazepine Acetate18$29,744
UbrelvyUbrogepant12$21,660
NeuproRotigotine20$21,055
Memantine Hcl ErMemantine Hcl244$20,034
Aimovig AutoinjectorErenumab-Aooe11$7,775
AdlarityDonepezil Hcl13$5,754
Carbamazepine ErCarbamazepine42$5,646
Lamotrigine ErLamotrigine17$3,361
Clobazam24$2,783

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$4,092$69,45246 claims
UCB, Inc.Briviact, Neupro$917$60,17446 claims
AbbVieQulipta, Ubrelvy$1,712$56,44643 claims
SK Life Science, Inc.Xcopri$812$31,67826 claims
Eisai Inc.Fycompa$1,423$30,52729 claims
Sunovion Pharmaceuticals Inc.Aptiom$444$29,74418 claims
Corium, LLCAdlarity$47$5,75413 claims
Upsher-smith Laboratories LLCTopiramate$112$18530 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,246 neurology providers in Texas.

Other neurology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →